Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Also known as: Blastic Plasmacytoid Dendritic Cell Neoplasm
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB14731 | Tagraxofusp | A CD123-directed cytotoxin used to treat plasmacytoid dendritic cell neoplasm. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB14731 | Tagraxofusp | Interleukin-3 receptor subunit alpha | target |
| DB14731 | Tagraxofusp | ADP-ribosylation factor-like protein 2 | target |